Saturday 17 October 2026 Export KNSA’s income statement to Excel — free account

Kiniksa Pharmaceuticals International, plc

KNSA Healthcare Drug Manufacturers Specialty & Generic

Kiniksa Pharmaceuticals International, plc’s revenue for fiscal 2025 (year ended December 2025) was $677.6 million, up 60.1% from fiscal 2024. In the quarter to June 2026, revenue grew 55.4%, EPS grew 37.5% and free cash flow grew 66.6%, each against the same quarter a year earlier. Revenue growth for three consecutive years, operating cash flow growth for five.

78.59 1.35 −1.69%

Follow KNSA

Alert me

Market cap: $6.2B
P/E: 73.4×
Fwd P/E: 38.7×
Dividend yield: —
F-score: 8/9
Altman Z: 10.35
Beneish M: −3.16
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	8	8	8	8
ROE Full definition →		7.39%	11.73%	13.74%	14.04%
ROA Full definition →		5.67%	8.78%	10.26%	10.36%
ROIC Full definition →		13.01%	31.44%	42.34%	48.87%
Return on Tangible Assets Full definition →		10.16%	15.13%	16.62%	16.13%
Average Days of Receivables Full definition →		31.58	8.40	11.24	10.20
Free Cash Flow per Share Full definition →		1.36	1.84	2.15	2.36
Free Cash Flow Full definition →		101.73	136.42	164.23	182.84
Capital Expenditures Full definition →		(1.13)	(1.57)	(1.63)	(2.13)
Other line items
Cash ROIC Full definition →		11.46%	13.90%	15.29%	15.49%
Accounts Receivable Turnover Full definition →		15.61	23.64	23.83	30.36
Accounts Payable Turnover Full definition →		10.31	38.20	6.11	8.01
Inventory Turnover Full definition →		2.13	1.91	1.69	1.44
Average Days of Payables Full definition →		30.08	9.53	110.50	52.91
Days of Inventory on Hand Full definition →		202.48	257.96	331.22	302.55
Tax Rate Full definition →		(0.26)	(0.34)	(0.31)	(0.29)
Research and Development Expense of Revenue Full definition →		16.30%	14.29%	13.93%	15.12%
Selling, General and Administrative Expense of Revenue Full definition →		30.11%	28.97%	28.37%	27.46%
Share Based Compensation of Revenue Full definition →		5.86%	5.46%	5.21%	5.00%
Operating CF/Net income Full definition →		2.86	2.34	2.27	2.29
Depreciation/Fixed assets Full definition →		0.90	0.80	0.84	0.70
Capex/Depreciation Full definition →		(0.76)	(1.01)	(0.97)	(1.19)
Revenue per Share Full definition →		8.00	9.13	9.85	10.84
Operating CF per Share Full definition →		1.38	1.86	2.17	2.38
Capex per Share Full definition →		(0.02)	(0.02)	(0.02)	(0.03)
Capex to Sales Full definition →		0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates

Stockrow Weekly